United States Sleep Apnea Devices Market, Size, Share, Forecast 2024-2030, Industry Trends, Growth, Insight, Types, Therapeutic Devices, Diagnostic Devices, End User, Countries and Company Analysis

United States Sleep Apnea Devices Market, Size, Share, Forecast 2024-2030, Industry Trends, Growth, Insight, Types, Therapeutic Devices, Diagnostic Devices, End User, Countries and Company Analysis

The United States Sleep Apnea Device Market is projected to expand from US$ 2.02 Billion in 2023 to a staggering US$ 3.76 Billion by 2032, demonstrating a robust CAGR of 7.12% during the period 2023-2032.

Sleep apnea is a common sleep disorder characterized by frequent interruptions in breathing during sleep. Symptoms include loud snoring and daytime drowsiness. It involves recurring episodes of reduced or halted breathing for short durations while asleep, leading to periodic awakenings and a decline in sleep quality. The market's upward trajectory is propelled by several factors, including the increasing prevalence of sleep apnea and rising awareness about the condition. However, the most significant driver is the continuous stream of technological advancements in sleep apnea devices. These innovations enhance the quality of life for sleep apnea patients and fuel the growth of the USA sleep apnea market, which is poised for substantial expansion in the foreseeable future.

The demand for sleep apnea devices is increasing due to the rising number of diagnosed cases of obstructive sleep apnea (OSA). A wide range of options is available, each designed to cater to specific patient needs. These include CPAP machines, oral appliances, and adaptive servo-ventilation devices. The introduction of advanced, user-friendly devices that offer improved comfort and efficacy is a key driver of market growth.

The main factors driving the sleep apnea devices market in the United States are:

• Rising incidences of sleep apnea
• Rising in the elderly population
• Increasing prevalence of obesity and hypertension
• Growing awareness among patients in the U.S.

The sleep apnea devices market in the USA is driven significantly by the aging population, which is at the highest risk of developing this disorder. The number of United States Americans aged 65 and older is predicted to reach 82 million by 2050 from 58 million in 2022. Additionally, the share of the total population represented by the 65-and-older age group is projected to rise from 17% to 23%.

More than 5.8 Million adults in the United States are accurately diagnosed with sleep apnea disease. Companies continually invest in R&D to improve device efficacy, comfort, and use. Partnerships and collaborations with healthcare providers and technical innovators are also becoming more frequent tactics for expanding market reach and providing comprehensive solutions.

Home care settings and individuals have a subnational market revenue

Home care settings and individuals are major end users of sleep apnea products in the United States, such as CPAP machines allowing for home therapy. This trend in healthcare towards home-based treatment enables people to manage their conditions without frequent hospitalization or clinic visits, improving compliance and long-term treatment plan adherence. Many insurance policies cover sleep apnea equipment for home use, making it more affordable. Using the equipment at home helps patients integrate therapy into their daily activities, promoting consistent use and improving treatment outcomes. In the United States, the American Sleep Apnea Association is a non-profit organization that raises awareness about sleep apnea, improves treatments, and advocates for the interests of sleep apnea patients.

United States Pulse Oximeters Market

Pulse oximeters are commonly used in healthcare to measure hemoglobin oxygen saturation. They are noninvasive and convenient, making them widely used in hospitals. The Pulse oximeters segment is expected to rise due to the increasing prevalence of sleep apnea in the USA. Ongoing developments, such as product launches and partnerships, will further boost the segment. For example, Tyto Care's FDA-cleared fingertip Pulse Oximeter allows for remote checking of blood oxygen saturation levels and heart rate launched in 2021.

United States Sleep Apnea Device Company Analysis

ResMed Inc., Carefusion Corp, Somnomed, Koninklijke Philips N.V., Compumedics, Natus Medical Incorporated, Teleflex Incorporated, and Fisher &Paykel Healthcare hold substantial shares in the United States Sleep Apnea Device market.

United States Sleep Apnea Device Company News

• Apr 2024, Fisher & Paykel Healthcare launches revolutionary F&P Solo™ Nasal mask for obstructive sleep apnea in the United States.
• In February 2024, ResMed introduced a new bi-level respiratory support device as an alternative to CPAP machines for treating sleep apnea.
• In November 2023, Vivos Therapeutics received clearance from the U.S. health regulator for its oral device to treat severe obstructive sleep apnea (OSA). This marks the first clearance for an oral appliance aimed at treating moderate and severe OSA in adults.
• May 2023, Acurable, a UK-based medical device company, will launch its AcuPebble device for obstructive sleep apnea diagnosis in the USA this summer after securing FDA clearance.

Types – Market breakup from 2 viewpoints:

1. Therapeutic Devices
2. Diagnostic Devices

Therapeutic Devices – Market have been further sub segmented from 4 viewpoints:

1. CPAP Sleep Apnea Therapeutic Devices
2. Auto CPAP Sleep Apnea Therapeutic Devices
3. BiPAP Sleep Apnea Therapeutic Devices
4. Adaptive Servo-Ventilation (ASV)

Diagnostic Devices – Market have been further sub segmented from 5 viewpoints:

1. Polysomnography Devices (PSG)
2. Oximeter
3. Actigraphy Monitoring Device
4. Respiratory Polygraph
5. Sleep Apnea Screening Device

End User – Market breakup from 2 viewpoints:

1. Sleep Laboratories, Clinics & Hospitals
2. Home Care Settings/Individuals

All key players have been covered from 3 viewpoints:

• Overview
• Recent Development
• Financial Insight

Company Analysis:

1. ResMed Inc.
2. Carefusion Corp
3. Somnomed
4. Koninklijke Philips N.V.
5. Compumedics
6. Natus Medical Incorporated
7. Teleflex Incorporated
8. Fisher & Paykel Healthcare